Role of serotonin in gastrointestinal physiology and pathology

Minerva Endocrinologica

Volumn 36, Issue 4, 2011, Pages 311-324

  Cirillo, C ^a,b   Vanden Berghe, P ^a,b   Tack, J ^b  

^a Laboratory for Enteric Neuroscience (LENS)   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Gastrointestinal diseases, pathophysiology; Metabolism; Serotonin

Indexed keywords

ALOSETRON; CISAPRIDE; MIANSERIN; MOSAPRIDE; ONDANSETRON; PRUCALOPRIDE; PUMOSETRAG; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TEGASEROD;

CONSTIPATION; DRUG EFFICACY; DRUG MECHANISM; DYSPEPSIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SECRETION; HORMONE ACTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; IRRITABLE COLON; ISCHEMIC COLITIS; MOOD; NAUSEA AND VOMITING; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UNSPECIFIED SIDE EFFECT;

ANIMALS; CONSTIPATION; DYSPEPSIA; ENTERIC NERVOUS SYSTEM; GASTROENTERITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; NEURONS; PAIN PERCEPTION; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN RECEPTOR AGONISTS; VAGUS NERVE; VISCERAL PAIN;

EID: 84858735005     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Erspamer V. Arch Fisiol 1937;37:156-69.
2. Janeway T, Richardson H, Park E. Experiments on the vasoconstrictor action of blood serum. Archives of Internal Medicine 1918;21:565-71.
3. Erspamer V, Asero B. Identification of enteramine, specific hormone of enterochromaffin cells, as 5-hydroxytryptamine. Nature1952;169:800-1.
4. Zucker M. A study of the substances in blood serum and platelets which stimulate smooth muscle. Am J Physiol 1944;142:12-26.
5. Brodie B, Shore P. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci 1957;66:631-42.
6. Costa M, Furness JB, Cuello AC, Verhofstad AA, Steinbusch HW, Elde RP. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment. Neuroscience 1982;7:351-63. (Pubitemid 12168724)
7. Yu PL, Fujimura M, Okumiya K, Kinoshita M, Hasegawa H, Fujimiya M. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J Comp Neurol 1999;411:654-65. (Pubitemid 29368195)
8. Tyce GM. Origin and metabolism of serotonin. J Cardiovasc Pharmacol 1990;16:S1-S7.
9. Clark C, Weissbach H, Udenfriend S. 5-hydroxytryptophan decarboxylase: preparation and properties. J Biol Chem;1954;210:139-48.
10. Noguchi T, Nishino M, Kido R. Tryptophan 5-hydroxylase in rat intestine. Biochem J 1973;131:375-80.
11. Kim M, Cooke HJ, Javed NH, Carvey HV, Christofi F, Raybould HE. D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 2001;121:1400-6.
12. Lomax RB, Gallego S, Novalbos J, Garcia AG, Warhurst G. L-type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: an in situ study. Gastroenterology 1999;117:1363-9.
13. Bertrand PP. Real time detection of serotonin release from enterochromaffine cells of the guinea-pig ileum. Neurogastroenterol Motil 2004;16:511-14. (Pubitemid 39472184)
14. Chen JX, Pan H, Rothman TP, Wade PR, Gershon MD. Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol 1998;275:G433-G48.
15. Li Z, Chalazonitis A, Huang YY, Mann JJ, Margolis KG, Yang QM et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci 2011;31:8998-9009.
16. Gebauer A, Merger M, Kilbinger H. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5- hydroxytryptamine from the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol 1993;347:137-40. (Pubitemid 23068164)
17. Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P et al. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 1995;115:622-8.
18. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-54. (Pubitemid 34219205)
19. Fletcher S, Barnes NM. Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes? Trends Pharmacol Sci 1998;19:212-5. (Pubitemid 28312165)
20. Tack J, Broekaert D, Coulie B, Fischler B, Janssens J. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003;17:603-8. (Pubitemid 36384820)
21. Tack JF, Janssens J,Vantrappen G, Wood JD. Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol 1992;263:G838-G46.
22. Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000;46:468-73. (Pubitemid 30305809)
23. Derkach V, Surprenant A, North R. 5-HT3 receptors are membrane ion channels. Nature 1989;339:706-9.
24. Gershon MD. Serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;20:3-14. (Pubitemid 39657670)
25. Fiebich BL, Akundi RS, Seidel M, Geyer V, Haus U, Müller W et al. Expression of 5-HT3A receptors in cells of the immune system. Scand J Rheumatol 2004;119:9-11. (Pubitemid 39180179)
26. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 2009;29:9683-99.
27. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-15. (Pubitemid 26120190)
28. Furness JB, Costa M. Types of nerves in the enteric nervous system. Neuroscience 1980;5:1-20. (Pubitemid 10203397)
29. Gershon MD, Drakontides AB, Ross LL. Serotonin: synthesis and release from the myenteric plexus of the mouse intestine. Science 1965;149:197-9.
30. Bülbring E, Gershon MD. 5-hydroxytryptamine participation in the vagal inhibitory innervation of the stomach. J Physiol 1967;192:823-46.
31. Gershon MD. Enteric serotonergic neurones... finally! J Physiol 2009;587:507.
32. Schemann M, Schaaf C, Mäder M. Neurochemical coding of enteric neurons in the guinea pig stomach. J Comp Neurol 1995;353:161-78.
33. Vanden Berghe P, Coulie B, Tack J, Mawe GM, Schemann M, Janssens J. Neurochemical coding of myenteric neurons in the guinea-pig antrum. Cell Tissue Res 1999;297:81-90. (Pubitemid 29313279)
34. Michel K, Sann H, Schaaf C, Schemann M. Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications. J Neurosci 1997;17:8009-17. (Pubitemid 27426236)
35. Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999;276:G373-7. (Pubitemid 29104150)
36. Wade PR, Wood JD. Actions of serotonin and substance P on myenteric neurons of guinea-pig distal colon. Eur J Pharmacol 1988;148:1-8. (Pubitemid 18082012)
37. Ito H, Tamura K. Inhibitory effect of YM060 on 5-HT3 receptor-mediated depolarization in colonic myenteric neurons of the guinea pig. Eur J Pharmacol 1995;283:107-12.
38. Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ et al. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology 2005;128:1317-26. (Pubitemid 40712182)
39. Lundgren O. 5-Hydroxytryptamine, enterotoxins, and intestinal fluid secretion. Gastroenterology 1998;115: 1009-12. (Pubitemid 28452950)
40. Ning Y, Zhu JX, Chan HC. Regulation of ion transport by 5-hydroxytryptamine in rat colon. Clin Exp Pharmacol Physiol 2004;31:424-8. (Pubitemid 39044121)
41. Gwynne RM, Ellis M, Sjövall H, Bornstein JC. Cholera toxin induces sustained hyperexcitability in submucosal secretomotor neurons in guinea pig jejunum. Gastroenterology 2009;136:299-308.
42. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008;55:1072-80.
43. Foong JP, Parry LJ, Gwynne RM, Bornstein JC. 5-HT(1A), SST(1), and SST(2) receptors mediate inhibitory postsynaptic potentials in the submucous plexus of the guinea pig ileum. Am J Physiol Gastrointest Liver Physiol 2010;298.G384-94.
44. Tack J, Sarnelli G. Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut 2002;51:77-80.
45. Morteau O, Julia V, Eeckhout C, Bueno L. Influence of 5-HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distention before and during experimental colitis in rats. Fundam Clin Pharmacol 1994;8:553-62.
46. Wei JY, Wang YH, Mayer E. The 5-HT4 receptor partial agonist, tegaserod, inhibits the colorectal distension-induced responses of rat inferior splanchnic afferents in vitro. Gastroenterology 2002;122:A-317.
47. Boesmans W, Owsianik G, Tack J, Voets T, Vanden Berghe P. TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 2011;162:18-37.
48. Ohta T, Ikemi Y, Murakami M, Imagawa T, Otsuguro K, Ito S. Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons. J Physiol 2006;576:809-22. (Pubitemid 44637885)
49. Zhang LY, Dong X, Liu ZL, Mo JZ, Fang JY, Xiao SD et al. Luminal serotonin time-dependently modulates vagal afferent driven antinociception in response to colorectal distention in rats. Neurogastroenterol Motil 2011;23:62-9.
50. Chen SL, Wu XY, Cao ZJ, Fan J, Wang M, Owyang C et al. Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol Gastrointest Liver Physiol 2008;294:G1441-9.
51. Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 2007;50:376-88. (Pubitemid 46394454)
52. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998;42:42-6. (Pubitemid 28228386)
53. Houghton LA, Atkinson W, Whitaker, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003;52:663-70. (Pubitemid 36528867)
54. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton L. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006;130:34-43. (Pubitemid 43049833)
55. Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 1994;35:496-500. (Pubitemid 24131246)
56. Brown PM, Drossman DA, Wood AJ, Cline GA, Frazier KS, Jackson JI et al. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology 2011;141:507-16.
57. Geeraerts B, Van Oudenhove L, Boesmans W, Vos R, Vanden Berghe P, Tack J. Influence of acute tryptophan depletion on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2011;300:G228-35.
58. El-Salhy M, Norrgård O, Spinnell S. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 1999;34:1007-11. (Pubitemid 29512870)
59. Zhao RH, Baig MK, Thaler KJ, Mack J, Abramson S, Woodhouse S et al. Reduced expression of serotonin receptor(s) in the left colon of patients with colonic inertia. Dis Colon Rectum 2003;46:81-6. (Pubitemid 36105835)
60. Costedio MM, Coates MD, Brooks EM, Glass LM, Ganguly EK, Blaszyk H et al. Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol 2010;105:1173-80.
61. O'Hara JR, Lomax AE, Mawe GM, Sharkey KA. Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon. Gut 2007;56:186-94.
62. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007;109:3139-46. (Pubitemid 46572497)
63. Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995;84:148-52.
64. Ahonen A, Kyosola K, Penttila O. Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res 1976;8:1-7.
65. Belai A, Boulos PB, Robson T, Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 1997;40:767-74. (Pubitemid 27305470)
66. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009;21:439-50.
67. Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol 2006;4:874-81. (Pubitemid 43994540)
68. Lee HG, Kim WM, Park CH, Yoon MH. Roles of adenosine and serotonin receptors on the antinociception of sildenafil in the spinal cord of rats. Yonsei Med J 2010;51:960-4.
69. Futagami S, Shindo T, Kawagoe T, Horie A, Shimpuku M, Gudis K et al. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol 2010;105:1835-42.
70. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010;31:883-91.
71. Motomura Y, Ghia JE, Wang H, Akiho H, El-Sharkawy RT, Collins M et al. Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut 2008;57:475-81. (Pubitemid 351442531)
72. Choi YD, Sung TS, Kim HJ, La JH, Kim TW, Yang IS. Increased 5-hydroxytryptamine mediates post-inflammatory visceral hypersensitivity via the 5-hydroxytryptamine 3 receptor in rats. Dig Dis Sci 2008;53:2909-16.
73. Coldwell JR, Phillis BD, Sutherland K, Howarth GS, Blackshaw LA. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J Physiol 2007;579(Pt 1):203-13.
74. Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G685-95.
75. Coates MD, Johnson AC, Greenwood- Van MB, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil 2006;18:464-71. (Pubitemid 43742561)
76. Bian X, Patel B, Dai X, Galligan JJ, Swain G. High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression. Gastroenterology 2007;132:2438-47. (Pubitemid 46890866)
77. Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003;285:G207-16. (Pubitemid 36736404)
78. Linden DR, Foley KF, McQuoid C, Simpson J, Sharkey KA, Mawe GM. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil 2005;17:565-74. (Pubitemid 41075999)
79. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-70. (Pubitemid 41748282)
80. Coates MD, Johnson AC, Greenwood-Van Meerveld B, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil 2006;18:464-71. (Pubitemid 43742561)
81. Costedio MM, Coates MD, Danielson AB, Buttolph TR 3rd, Blaszyk HJ, Mawe GM et al. Serotonin signaling in diverticular disease. J Gastrointest Surg 2008;12:1439-45.
82. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-64. (Pubitemid 38736329)
83. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007;132:17-25. (Pubitemid 46108754)
84. Coleman NS, Marciani L, Blackshaw E, Wright J, Parker M, Yano T et al. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther 2003;18:1039-48. (Pubitemid 37475965)
85. Fujita T, Yokota S, Sawada M, Majima M, Ohtani Y, Kumagai Y. Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study. J Clin Pharm Ther 2005;30:611-22. (Pubitemid 43960989)
86. Zerbib F, Bruley des Varannes S, Oriola RC, McDonald J, Isal JP, Galmiche JP. Alosetron does not affect the visceral perception of gastric distension in healthy subjects. Aliment Pharmacol Ther 1994;8:403-7. (Pubitemid 24257556)
87. Feinle C, Read NW. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am J Physiol 1996;271:G591-7.
88. Machu TK. Therapeutics of 5-HT3 receptor antagonists: current uses and future directions. Pharmacol Ther 2011;130:338-47.
89. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001;15:525-37. (Pubitemid 32242779)
90. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR et al. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990;35:477-80. (Pubitemid 20116748)
91. Camilleri M, Northcutt AR, Kong SA, Dukes GE, McSorley D, Mangel AM. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000;355:1035-40. (Pubitemid 30162805)
92. Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009;104:1831-43.
93. Cellek S, John AK, Thangiah R, Dass NB, Bassil AK, Jarvie EM et al. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 2006;18:853-61. (Pubitemid 44201172)
94. Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA. 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. BrJ Pharmacol 2000;131:927-32.
95. Tam FS, Hillier K, Bunce KT. Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol 1994;113:143-50. (Pubitemid 24271730)
96. Tsuchida Y, Hatao F, Fujisawa M, Murata T, Kaminishi M, Seto Y et al. Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus. Gut 2011;60:638-47.
97. 2B receptor antagonist inhibits visceral hypersensitivity in rats Neurogastroenterol Motil 2010;22:e69-76.
98. Tack J, Van Den Elzen B, Tytgat G, Wajs E, Van Nueten L, De Ridder F et al. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Neurogastroenterol Motil 2009;21:619-26.
99. Sifrim D, Holloway RH, Tack J, Zelter A, Missotten T, Coulie B et al. Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 1999;94:3158-64.
100. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996;31:318-25. (Pubitemid 26117753)